Caribou Biosciences, Inc.
CRBU
$1.86
$0.105.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.59% | 13.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.59% | 13.34% | |||
| Cost of Revenue | -6.63% | -25.53% | |||
| Gross Profit | -27.98% | 124.43% | |||
| SG&A Expenses | -11.59% | 6.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.05% | -15.84% | |||
| Operating Income | 17.01% | 17.44% | |||
| Income Before Tax | 49.08% | -35.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 49.08% | -35.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.08% | -35.28% | |||
| EBIT | 17.01% | 17.44% | |||
| EBITDA | 16.03% | 17.93% | |||
| EPS Basic | 49.22% | -34.76% | |||
| Normalized Basic EPS | 34.49% | -4.49% | |||
| EPS Diluted | 49.22% | -34.76% | |||
| Normalized Diluted EPS | 34.49% | -4.49% | |||
| Average Basic Shares Outstanding | 0.28% | 0.38% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||